Paul Cool

Professor

Keele University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paul Cool is a Professor at Keele University in the United Kingdom. His research primarily focuses on the fields of cancer genomics, infectious diseases, and orthopedic oncology. Recent publications include studies on nanopore sequencing for bacterial identification in joint infections and genomic analysis of musculoskeletal metastases. He is also involved in assessing the prognostic indicators following spinal cord injury and adherence to management guidelines in metastatic bone disease.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED KINGDOM

View details

Robert Ashford

University of Leicester

UNITED KINGDOM

View details

Iben Lyskjær

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Cool

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Rapid Nanopore Sequencing to Identify Bacteria Causing Prosthetic Joint Infections

The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma

Bone amyloidosis: A rare case in a young adult

A Comprehensive Proteomic and Bioinformatic Analysis of Human Spinal Cord Injury Plasma Identifies Proteins Associated with the Complement Cascade and Liver Function as Potential Prognostic Indicators of Neurological Outcome

The Genomic Analysis of Patients with Musculoskeletal Metastases from an Unknown Origin.

Poor adherence to national guidance in the management of patients with metastatic bone disease

Using nanopore sequencing to identify bacterial infection in joint replacements: a preliminary study

Clinical outcome of open ankle fractures in patients above 70 years of age

Genomic Sequencing to Diagnose Prosthetic Joint Infection in the Knee: A Case Report

Poor adherence to national guidance in the management of patients with metastatic bone disease

The British Orthopaedic Oncology Management (BOOM) audit

Machine learning models based on routinely sampled blood tests can predict the presence of malignancy amongst patients with suspected musculoskeletal malignancy

A genetic model for central chondrosarcoma evolution correlates with patient outcome

Mirels’ score for upper limb metastatic lesions: do we need a different cutoff for recommending prophylactic fixation?

Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations

Distal femoral replacement – Does length matter? Mid-term results for distal femoral replacements

Joint replacement surgery for elbow tumours: a systematic review of outcomes

How a Pandemic Changes Trauma: Epidemiology and Management of Trauma Admissions in the UK during COVID-19 Lockdown.

Venous thromboembolism in orthopaedic oncology

What Proportion of Patients with Bone and Soft-Tissue Tumors Contracted Coronavirus-19 and Died From Surgical Procedures During the Initial Period of the COVID-19 Pandemic? Results From the Multicenter British Orthopaedic Oncology Society Observational Study

Collaborators (8)

Charlotte Hulme

Tosan Okoro

ARPIT JARIWALA

Steven Hargreaves

William Cross

David Barnes

Robert Ashford

Iben Lyskjær

Make your next move.